Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Konrad H. Stopsack, M.D.

Title
Institution
Department
Address
Profile Picture

Biography
University of Freiburg, Freiburg, GermanyMD2013Medicine
Harvard School of Public Health, Boston, MAMPH2014Biostatistics and Epidemiology
Mayo Clinic, Rochester, MNResidency, Board certification2017Internal Medicine
Memorial Sloan Kettering Cancer Center, New York, NYPostdoctoral training2021Cancer Epidemiology

Overview
I am a molecular and clinical epidemiologist with a focus on cancer epidemiology and a background as a board-certified internal medicine physician. My main research interest is how potentially modifiable exposures cause solid tumors through genomic heterogeneity and influence cancer progression. I am passionate about combining well-defined observational studies and state-of-the-art genomics in order to guide cancer prevention and treatment. My methodologic and teaching interests include application and further development of epidemiologic methods for high-dimensional biomarker studies and clinical studies.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R37CA275914 (STOPSACK, KONRAD HERMANN) Aug 1, 2023 - Jul 31, 2028
    NIH
    Etiologic Heterogeneity Between Molecular Subtypes of Prostate Cancer
    Role: Principal Investigator
  2. P01CA228696 (OFFIT, KENNETH) Sep 1, 2019 - Aug 31, 2025
    NIH
    The Impact of DNA Damage Repair Abnormalities in Prostate Cancer
    Role: Co-Investigator
  3. 17YOUN16 (Stopsack)
    Prostate Cancer Foundation
    Young Investigator Award: Intratumoral cholesterol metabolism to guide prostate cancer therapy
    Role: PI
  4. Challenge Award (Kantoff)
    Prostate Cancer Foundation
    Clonal hematopoiesis in prostate cancer
    Role: Co-Investigator
  5. Traditional Bridge Grant (Amon/Mucci)
    Harvard–MIT Bridge Program
    Credentialing aneuploidy as a prognostic biomarker in prostate cancer
    Role: Co-Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Updating...
This operation might take several minutes to complete. Please do not close your browser.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu.
Stopsack's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (252)
Explore
_
Co-Authors (65)
Explore
_
Similar People (58)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.